Hemodialysis Catheter
Haolang Medical U
FDA Clearance Information
The hemodialysis catheter by Haolang Medical U was cleared via the FDA 510(k) pathway on May 16, 2025. It is classified as a Class 2 device under product code MSD.
What It Is
FDA-Cleared Indications
- Vascular access for hemodialysis.
- Access for removing and returning blood during hemodialysis treatments.
- Use as an implanted hemodialysis catheter when dialysis access is required.
Clinical Applications
- Providing central venous access for patients receiving hemodialysis.
- Connecting a patient to the dialysis circuit for blood removal and return.
- Providing dialysis access when an arteriovenous fistula or graft is not available, cannot be used, or is not yet ready.
- Providing longer-term vascular access when clinically indicated and consistent with the device labeling.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Catheters are available in different lengths, diameters, lumen configurations, and cuffed or noncuffed designs; selection depends on the patient’s anatomy, access site, dialysis requirements, and manufacturer labeling.
- Common central venous access sites include the internal jugular, femoral, and subclavian veins. The access site affects infection risk, thrombosis risk, vessel preservation, and future fistula or graft options.
- Placement and confirmation are generally performed with ultrasound and fluoroscopic or other imaging guidance, using sterile technique. Local anesthesia with or without moderate sedation may be used.
- MRI compatibility is device-specific. The exact catheter model, labeling, and any associated clamps or connectors should be checked before MRI.
- Potential complications include infection, bleeding, venous thrombosis or stenosis, catheter malfunction, air embolism, vessel injury, and inadequate dialysis flow. Contraindications and precautions depend on the patient and the specific device labeling.
Frequently Asked Questions
What are the clinical indications for hemodialysis catheter?
The hemodialysis catheter is indicated for vascular access in patients requiring hemodialysis, particularly those with end-stage renal disease.
What outcomes have been reported in clinical studies?
Studies have reported outcomes related to thrombosis and infection management, with some interventions showing promise in reducing these complications.
What complications have been reported?
Safety data from evidence indicate complications such as catheter-related thrombosis and bloodstream infections.